Elzayat, E.M.; Sherif, A.Y.; Nasr, F.A.; Attwa, M.W.; Alshora, D.H.; Ahmad, S.F.; Alqahtani, A.S.
Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles. Materials 2023, 16, 5364.
https://doi.org/10.3390/ma16155364
AMA Style
Elzayat EM, Sherif AY, Nasr FA, Attwa MW, Alshora DH, Ahmad SF, Alqahtani AS.
Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles. Materials. 2023; 16(15):5364.
https://doi.org/10.3390/ma16155364
Chicago/Turabian Style
Elzayat, Ehab M., Abdelrahman Y. Sherif, Fahd A. Nasr, Mohamed W. Attwa, Doaa H. Alshora, Sheikh F. Ahmad, and Ali S. Alqahtani.
2023. "Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles" Materials 16, no. 15: 5364.
https://doi.org/10.3390/ma16155364
APA Style
Elzayat, E. M., Sherif, A. Y., Nasr, F. A., Attwa, M. W., Alshora, D. H., Ahmad, S. F., & Alqahtani, A. S.
(2023). Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles. Materials, 16(15), 5364.
https://doi.org/10.3390/ma16155364
